×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [31]
西安交通大学 [13]
西北高原生物研究所 [10]
山东大学 [10]
上海中医药大学 [10]
复旦大学上海医学院 [9]
更多...
内容类型
期刊论文 [152]
学位论文 [10]
会议论文 [1]
发表日期
2019 [20]
2018 [13]
2017 [15]
2016 [15]
2015 [18]
2014 [12]
更多...
学科主题
Pharmacolo... [6]
Chemistry [2]
Immunology [2]
research &... [2]
Biochemist... [1]
Chemistry,... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共163条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models
期刊论文
ARTHRITIS RESEARCH & THERAPY, 2019, 卷号: 21, 期号: 1, 页码: 15
作者:
Zhang, Zongwang
;
Wu, Yanwei
;
Wu, Bing
;
Qi, Qing
;
Li, Heng
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2020/07/01
Systemic sclerosis
SAHH inhibitor
Fibrosis
Inflammation
Vasculopathy
TGF-beta
(5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice
期刊论文
LIFE SCIENCES, 2019, 卷号: 232, 页码: 9
作者:
Dong, Yunxia
;
Lu, Henglei
;
Li, Qiang
;
Qi, Xinming
;
Li, Yuanchao
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2020/07/01
(5R)-5-hydroxytriptolide
NAFLD
Lipid synthesis
Fatty acids oxidation
Fat deposition
In situ hexagonal liquid crystal for intra-articular delivery of sinomenine hydrochloride
期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2019, 卷号: 117, 页码: 8
作者:
Liang, Xiao
;
Chen, Yulin
;
Wu, Li
;
Maharjan, Abi
;
Regmi, Balmukunda
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2020/07/01
In Situ hexagonal liquid crystal
Sinomenine hydrochloride
Rheumatoid arthritis
Sustained release
Intra-articular administration
Deficiency of beta-Arrestin 2 in Dendritic Cells Contributes to Autoimmune Diseases
期刊论文
JOURNAL OF IMMUNOLOGY, 2019, 卷号: 202, 期号: 2, 页码: 407-420
作者:
Cai, Yingying
;
Yang, Cuixia
;
Yu, Xiaohan
;
Qian, Jie
;
Dai, Min
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2020/07/01
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/12/04
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Fangchinoline supplementation attenuates inflammatory markers in experimental rheumatoid arthritis-induced rats
期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2019, 卷号: 111
作者:
Li, Shan
;
Liu, Tong
;
Li, Hang
;
Fan, Hongwu
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/05
Fangchinoline
Inflammation
Rats
Chondrocyte
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Li, X.
;
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Treatment of patients with systemic-onset juvenile idiopathic arthritis with tacrolimus
期刊论文
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 卷号: 17, 期号: 3
作者:
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
treatment
systemic-onset juvenile idiopathic arthritis
tacrolimus
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
©版权所有 ©2017 CSpace - Powered by
CSpace